5-(6-chloropyrimidin-4-yl)-2-(oxan-4-yloxy)benzonitrile;4-methoxy-5-(1-methylpiperidin-4-yl)pyridin-2-amine;5-[6-[[4-methoxy-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrimidin-4-yl]-2-(oxan-4-yloxy)benzonitrile
C56H65ClN12O6 — CID 159438506
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(6-chloropyrimidin-4-yl)-2-(oxan-4-yloxy)benzonitrile;4-methoxy-5-(1-methylpiperidin-4-yl)pyridin-2-amine;5-[6-[[4-methoxy-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrimidin-4-yl]-2-(oxan-4-yloxy)benzonitrile
5-(6-chloropyrimidin-4-yl)-2-(oxan-4-yloxy)benzonitrile;4-methoxy-5-(1-methylpiperidin-4-yl)pyridin-2-amine;5-[6-[[4-methoxy-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrimidin-4-yl]-2-(oxan-4-yloxy)benzonitrile (PubChem CID 159438506) has the molecular formula C56H65ClN12O6 and a molecular weight of 1037.67 g/mol. Its IUPAC name is 5-(6-chloropyrimidin-4-yl)-2-(oxan-4-yloxy)benzonitrile;4-methoxy-5-(1-methylpiperidin-4-yl)pyridin-2-amine;5-[6-[[4-methoxy-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrimidin-4-yl]-2-(oxan-4-yloxy)benzonitrile.
Molecular Properties
| Compound Name | 5-(6-chloropyrimidin-4-yl)-2-(oxan-4-yloxy)benzonitrile;4-methoxy-5-(1-methylpiperidin-4-yl)pyridin-2-amine;5-[6-[[4-methoxy-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrimidin-4-yl]-2-(oxan-4-yloxy)benzonitrile |
|---|---|
| PubChem CID | 159438506 |
| Molecular Formula | C56H65ClN12O6 |
| Molecular Weight | 1037.67 g/mol |
| Exact Mass | 1036.48 |
| IUPAC Name | 5-(6-chloropyrimidin-4-yl)-2-(oxan-4-yloxy)benzonitrile;4-methoxy-5-(1-methylpiperidin-4-yl)pyridin-2-amine;5-[6-[[4-methoxy-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrimidin-4-yl]-2-(oxan-4-yloxy)benzonitrile |
| SMILES | COc1cc(N)ncc1C1CCN(C)CC1.COc1cc(Nc2cc(-c3ccc(OC4CCOCC4)c(C#N)c3)ncn2)ncc1C1CCN(C)CC1.N#Cc1cc(-c2cc(Cl)ncn2)ccc1OC1CCOCC1 |
| InChI | InChI=1S/C28H32N6O3.C16H14ClN3O2.C12H19N3O/c1-34-9-5-19(6-10-34)23-17-30-28(15-26(23)35-2)33-27-14-24(31-18-32-27)20-3-4-25(21(13-20)16-29)37-22-7-11-36-12-8-22;17-16-8-14(19-10-20-16)11-1-2-15(12(7-11)9-18)22-13-3-5-21-6-4-13;1-15-5-3-9(4-6-15)10-8-14-12(13)7-11(10)16-2/h3-4,13-15,17-19,22H,5-12H2,1-2H3,(H,30,31,32,33);1-2,7-8,10,13H,3-6H2;7-9H,3-6H2,1-2H3,(H2,13,14) |
| InChIKey | LRWLFYUBSFQMOL-UHFFFAOYSA-N |
| XLogP | 9.24 |
| TPSA | 224.83 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 75 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1037.67 |
| LogP ≤ 5 | 9.24 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 18 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159438506 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.